Skip to main content

Published locations for FDA expands Xofluza indication to include postexposure flu prophylaxis

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. FDA expands Xofluza indication to include postexposure flu prophylaxis

User login

  • Reset your password
  • /content/fda-expands-xofluza-indication-include-postexposure-flu-prophylaxis
  • /familypracticenews/article/232514/infectious-diseases/fda-expands-xofluza-indication-include
  • /fedprac/article/232514/infectious-diseases/fda-expands-xofluza-indication-include-postexposure-flu
  • /idpractitioner/article/232514/infectious-diseases/fda-expands-xofluza-indication-include
  • /internalmedicinenews/article/232514/infectious-diseases/fda-expands-xofluza-indication-include
  • /obgynnews/article/232514/infectious-diseases/fda-expands-xofluza-indication-include-postexposure-flu
  • /pediatricnews/article/232514/infectious-diseases/fda-expands-xofluza-indication-include-postexposure
  • /hospitalist/article/232514/infectious-diseases/fda-expands-xofluza-indication-include-postexposure
  • /pulmonary-health-hub/article/232514/infectious-diseases/fda-expands-xofluza-indication-include
  • /jcomjournal/article/232514/infectious-diseases/fda-expands-xofluza-indication-include-postexposure
  • /obgyn/article/232514/infectious-diseases/fda-expands-xofluza-indication-include-postexposure-flu
  • /ecardiologynews/article/232514/infectious-diseases/fda-expands-xofluza-indication-include
  • /pediatrics/article/232514/infectious-diseases/fda-expands-xofluza-indication-include-postexposure
  • /cardiology/article/232514/infectious-diseases/fda-expands-xofluza-indication-include-postexposure
  • /infectiousdisease/article/232514/infectious-diseases/fda-expands-xofluza-indication-include
  • /internalmedicine/article/232514/infectious-diseases/fda-expands-xofluza-indication-include
  • /familymedicine/article/232514/infectious-diseases/fda-expands-xofluza-indication-include
  • /chestphysician/article/232514/infectious-diseases/fda-expands-xofluza-indication-include